VUSN PHARM EXAM LATEST
2 (WEEK EIGHT)
selective estrogen receptor modulators - ANSWERS-raloxifene class
prevention and treatment of postmenopausal osteoporosis in female pts -
ANSWERS-raloxifene use
activate estrogen receptors in some tissues and block receptors in other
tissues, activation decreases bone resorption and bone loss -
ANSWERS-raloxifene ETA
elevated serum lipid levels - ANSWERS-raloxifene precautions
active or hx of VTE, pts on estrogen therapy - ANSWERS-raloxifene
contraindications
PO (daily) - ANSWERS-raloxifene admin
hot flashes, VTE/PE, stroke - ANSWERS-raloxifene side effects
END OF
PAGE
1
, VUSN PHARM EXAM LATEST
2 (WEEK EIGHT)
do not use w estrogen (too much increases risk for uterine cancer) -
ANSWERS-raloxifene interactions
observe for s/sx of VTE/PE, monitor bone density - ANSWERS-
raloxifene nursing interventions
educate about side effects, can take with or without food, do not take
estrogen replacement therapy during treatment, encourage Ca, Vitamin
D, weight bearing exercise - ANSWERS-raloxifene patient education
calcitonin - ANSWERS-calcitonin-salmon class
treatment of postmenopausal osteoporosis in female pts - ANSWERS-
calcitonin-salmon use
inhibits action of osteoclasts, decreases bone resorption - ANSWERS-
calcitonin-salmon ETA
allergy to salmon, prior treatment w bisphosphonate - ANSWERS-
calcitonin-salmon contraindications
END OF
PAGE
2
, VUSN PHARM EXAM LATEST
2 (WEEK EIGHT)
intranasal (daily, on nostril), IM, sub-q (daily, decreased therapeutic
effects over time) - ANSWERS-calcitonin-salmon admin
may decrease serum lithium levels, previous treatment w bisphosphonate
may decrease response to calcitonin - ANSWERS-calcitonin-salmon
interactions
nasal dryness and irritation (epistaxis), HA, injection site reactions,
N&V, polyuria, hypocalcemia, hypersensitivity/anaphylaxis reactions -
ANSWERS-calcitonin-salmon side effects
give first injection in office to monitor for hypersensitivity reaction,
monitor for hypocalcemia, assess nostrils/nasal passageway for
irritation/ulceration prior to inhaled use, monitor bone density -
ANSWERS-calcitonin-salmon nursing interventions
educate about side effects, encourage Ca, Vitamin D, weight bearing
exercise, notify provider of muscle spasms, tingling of fingers and toes
(hypocalcemia),
- Intranasal: hold nasal pump upright, only spray one nostril, alternate
nostril daily
END OF
PAGE
3
2 (WEEK EIGHT)
selective estrogen receptor modulators - ANSWERS-raloxifene class
prevention and treatment of postmenopausal osteoporosis in female pts -
ANSWERS-raloxifene use
activate estrogen receptors in some tissues and block receptors in other
tissues, activation decreases bone resorption and bone loss -
ANSWERS-raloxifene ETA
elevated serum lipid levels - ANSWERS-raloxifene precautions
active or hx of VTE, pts on estrogen therapy - ANSWERS-raloxifene
contraindications
PO (daily) - ANSWERS-raloxifene admin
hot flashes, VTE/PE, stroke - ANSWERS-raloxifene side effects
END OF
PAGE
1
, VUSN PHARM EXAM LATEST
2 (WEEK EIGHT)
do not use w estrogen (too much increases risk for uterine cancer) -
ANSWERS-raloxifene interactions
observe for s/sx of VTE/PE, monitor bone density - ANSWERS-
raloxifene nursing interventions
educate about side effects, can take with or without food, do not take
estrogen replacement therapy during treatment, encourage Ca, Vitamin
D, weight bearing exercise - ANSWERS-raloxifene patient education
calcitonin - ANSWERS-calcitonin-salmon class
treatment of postmenopausal osteoporosis in female pts - ANSWERS-
calcitonin-salmon use
inhibits action of osteoclasts, decreases bone resorption - ANSWERS-
calcitonin-salmon ETA
allergy to salmon, prior treatment w bisphosphonate - ANSWERS-
calcitonin-salmon contraindications
END OF
PAGE
2
, VUSN PHARM EXAM LATEST
2 (WEEK EIGHT)
intranasal (daily, on nostril), IM, sub-q (daily, decreased therapeutic
effects over time) - ANSWERS-calcitonin-salmon admin
may decrease serum lithium levels, previous treatment w bisphosphonate
may decrease response to calcitonin - ANSWERS-calcitonin-salmon
interactions
nasal dryness and irritation (epistaxis), HA, injection site reactions,
N&V, polyuria, hypocalcemia, hypersensitivity/anaphylaxis reactions -
ANSWERS-calcitonin-salmon side effects
give first injection in office to monitor for hypersensitivity reaction,
monitor for hypocalcemia, assess nostrils/nasal passageway for
irritation/ulceration prior to inhaled use, monitor bone density -
ANSWERS-calcitonin-salmon nursing interventions
educate about side effects, encourage Ca, Vitamin D, weight bearing
exercise, notify provider of muscle spasms, tingling of fingers and toes
(hypocalcemia),
- Intranasal: hold nasal pump upright, only spray one nostril, alternate
nostril daily
END OF
PAGE
3
